LPCN logo

Lipocine (LPCN) EBITDA

Annual EBITDA

-$16.32 M
-$5.60 M-52.24%

December 31, 2023

Summary

Performance

1-Year Change

-52.24%

3-Year Change

+20.67%

5-Year Change

-44.36%

15-Year Change

+22.97%

LPCN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.8%
LPCN annual EBITDA is higher than 56.8% of companies in Healthcare sector

High & Low

All-time High

-$5200.00

3-Year Low

-$16.32 M
LPCN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LPCN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
LPCN next annual earnings announcement is scheduled for Mar 7, 2025

OtherLPCNprofitabilitymetrics:

Annual Revenue

-$2.85 M
LPCN annual revenue is -$2.85 million

Annual Net Income

-$16.35 M
LPCN annual net profit is -$16.35 million

Annual EBIT

-$16.35 M
LPCN annual earnings before interest & taxes is -$16.35 million

Annual EPS

-$3.14
LPCN annual earnings per share is -$3.14

Quarterly EBITDA

-$2.62 M
+$662.10 K+20.16%

September 30, 2024

Summary

Performance

3-Month Change

+20.16%

1-Year Change

-160.71%

3-Year Change

+33.58%

5-Year Change

+33.58%

LPCN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.19%
LPCN quarterly EBITDA is higher than 59.19% of companies in Healthcare sector

High & Low

All-time High

$12.66 M
LPCN quarterly EBITDA is currently -120.72% below its historical high of $12.66 million

3-Year Low

-$7.04 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LPCN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
LPCN next earnings announcement is scheduled for Mar 7, 2025

OtherLPCNprofitabilitymetrics:

Quarterly Revenue

-
LPCN quarterly revenue value is unknown

Quarterly Net Income

-$2.22 M
LPCN quarterly net profit is -$2.22 million

Quarterly EBIT

-$2.63 M
LPCN quarterly earnings before interest & taxes is -$2.63 million

Quarterly EPS

-$0.44
LPCN quarterly earnings per share is -$0.44

TTM EBITDA

-$3.68 M
+$4.41 M+54.53%

September 30, 2024

Summary

Performance

3-Month Change

+54.53%

1-Year Change

+77.45%

3-Year Change

+71.5%

5-Year Change

+71.5%

LPCN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.13%
LPCN TTM EBITDA is higher than 73.13% of companies in Healthcare sector

High & Low

All-time High

$4.16 M
LPCN TTM EBITDA is currently -188.44% below its historical high of $4.16 million

3-Year Low

-$17.54 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LPCN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
LPCN next earnings announcement is scheduled for Mar 7, 2025

OtherLPCNprofitabilitymetrics:

TTM Revenue

-
LPCN TTM revenue value is unknown

TTM Net Income

-$4.06 M
LPCN TTM net profit is -$4.06 million

TTM EBIT

-$3.71 M
LPCN TTM earnings before interest & taxes is -$3.71 million

TTM EPS

-$0.77
LPCN TTM earnings per share is -$0.77

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$16.32 M
LPCN annual EBITDA is -$16.32 million

Annual Net Income

-$16.35 M
LPCN annual net profit is -$16.35 million

Annual Interest Expense

$0.00
LPCN annual interest expense is $0.00

Annual Income Tax

$800.00
LPCN annual income tax is $800.00

Annual D&A

$28.70 K
LPCN annual depreciation & amortization is $28.70 thousand

LPCN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-52.2%-160.7%+77.5%
3 y3 years+20.7%+33.6%+71.5%
5 y5 years-44.4%+33.6%+71.5%

LPCN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3691.6%at low-120.7%+62.7%-188.4%+79.0%
5 y5-year-3691.6%+20.7%-120.7%+62.7%-188.4%+82.1%
alltimeall time<-9999.0%+23.0%-120.7%+62.9%-188.4%+84.7%

Lipocine EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.62 M(-20.2%)
-$3.68 M(-54.5%)
Jun 2024
-
-$3.28 M(-201.6%)
-$8.09 M(-7.6%)
Mar 2024
-
$3.23 M(-421.3%)
-$8.76 M(-46.3%)
Dec 2023
-$16.32 M(+52.2%)
-$1.01 M(-85.7%)
-$16.32 M(-7.0%)
Sep 2023
-
-$7.04 M(+78.2%)
-$17.54 M(+35.8%)
Jun 2023
-
-$3.95 M(-8.9%)
-$12.91 M(+11.4%)
Mar 2023
-
-$4.33 M(+94.6%)
-$11.59 M(+8.1%)
Dec 2022
-$10.72 M(+2390.5%)
-$2.23 M(-7.5%)
-$10.72 M(-357.6%)
Sep 2022
-
-$2.41 M(-8.2%)
$4.16 M(+17.8%)
Jun 2022
-
-$2.62 M(-24.4%)
$3.53 M(-690.8%)
Mar 2022
-
-$3.47 M(-127.4%)
-$597.90 K(+38.9%)
Dec 2021
-$430.50 K(-97.9%)
$12.66 M(-516.8%)
-$430.50 K(-97.5%)
Sep 2021
-
-$3.04 M(-55.0%)
-$17.52 M(-6.4%)
Jun 2021
-
-$6.75 M(+104.7%)
-$18.71 M(+2.6%)
Mar 2021
-
-$3.30 M(-25.5%)
-$18.24 M(-11.4%)
Dec 2020
-$20.57 M(+68.3%)
-$4.43 M(+4.7%)
-$20.57 M(+6.7%)
Sep 2020
-
-$4.23 M(-32.7%)
-$19.28 M(+7.6%)
Jun 2020
-
-$6.28 M(+11.4%)
-$17.92 M(+20.6%)
Mar 2020
-
-$5.64 M(+79.9%)
-$14.86 M(+21.6%)
Dec 2019
-$12.22 M(+8.1%)
-$3.13 M(+9.1%)
-$12.22 M(-3.0%)
Sep 2019
-
-$2.87 M(-10.8%)
-$12.60 M(+5.3%)
Jun 2019
-
-$3.22 M(+7.5%)
-$11.96 M(+1.5%)
Mar 2019
-
-$3.00 M(-14.6%)
-$11.78 M(+4.2%)
Dec 2018
-$11.31 M
-$3.51 M(+57.0%)
-$11.31 M(-15.3%)
Sep 2018
-
-$2.24 M(-26.4%)
-$13.36 M(-15.5%)
Jun 2018
-
-$3.04 M(+20.5%)
-$15.81 M(-16.1%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$2.52 M(-54.7%)
-$18.86 M(-11.2%)
Dec 2017
-$21.19 M(+15.0%)
-$5.56 M(+18.5%)
-$21.24 M(+15.8%)
Sep 2017
-
-$4.69 M(-22.8%)
-$18.34 M(+10.9%)
Jun 2017
-
-$6.08 M(+24.1%)
-$16.54 M(+1.7%)
Mar 2017
-
-$4.90 M(+84.0%)
-$16.26 M(-11.7%)
Dec 2016
-$18.43 M(+0.4%)
-$2.66 M(-7.9%)
-$18.43 M(-9.9%)
Sep 2016
-
-$2.89 M(-50.2%)
-$20.45 M(-14.7%)
Jun 2016
-
-$5.81 M(-17.8%)
-$23.98 M(+6.8%)
Mar 2016
-
-$7.06 M(+50.6%)
-$22.45 M(+22.3%)
Dec 2015
-$18.36 M(-10.3%)
-$4.69 M(-27.0%)
-$18.36 M(+3.6%)
Sep 2015
-
-$6.42 M(+50.3%)
-$17.72 M(+15.0%)
Jun 2015
-
-$4.27 M(+43.9%)
-$15.41 M(-15.1%)
Mar 2015
-
-$2.97 M(-26.8%)
-$18.15 M(-11.3%)
Dec 2014
-$20.47 M(+134.3%)
-$4.05 M(-1.5%)
-$20.47 M(+2.8%)
Sep 2014
-
-$4.12 M(-41.3%)
-$19.90 M(+7.4%)
Jun 2014
-
-$7.01 M(+32.5%)
-$18.54 M(+60.7%)
Mar 2014
-
-$5.29 M(+51.4%)
-$11.54 M(+84.6%)
Dec 2013
-$8.74 M(>+9900.0%)
-$3.49 M(+27.0%)
-$6.25 M(-17.7%)
Sep 2013
-
-$2.75 M(>+9900.0%)
-$7.59 M(+29.7%)
Jun 2013
-
-$3100.00(-3.1%)
-$5.85 M(-1.0%)
Mar 2013
-
-$3200.00(-99.9%)
-$5.91 M(-0.0%)
Dec 2012
-$76.70 K(+1375.0%)
-$4.83 M(+376.2%)
-$5.91 M(+447.1%)
Sep 2012
-
-$1.01 M(+1558.5%)
-$1.08 M(+1537.9%)
Jun 2012
-
-$61.20 K(+1175.0%)
-$66.00 K(+1275.0%)
Mar 2012
-
-$4800.00
-$4800.00
Dec 2011
-$5200.00
-
-

FAQ

  • What is Lipocine annual EBITDA?
  • What is the all time high annual EBITDA for Lipocine?
  • What is Lipocine annual EBITDA year-on-year change?
  • What is Lipocine quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Lipocine?
  • What is Lipocine quarterly EBITDA year-on-year change?
  • What is Lipocine TTM EBITDA?
  • What is the all time high TTM EBITDA for Lipocine?
  • What is Lipocine TTM EBITDA year-on-year change?

What is Lipocine annual EBITDA?

The current annual EBITDA of LPCN is -$16.32 M

What is the all time high annual EBITDA for Lipocine?

Lipocine all-time high annual EBITDA is -$5200.00

What is Lipocine annual EBITDA year-on-year change?

Over the past year, LPCN annual EBITDA has changed by -$5.60 M (-52.24%)

What is Lipocine quarterly EBITDA?

The current quarterly EBITDA of LPCN is -$2.62 M

What is the all time high quarterly EBITDA for Lipocine?

Lipocine all-time high quarterly EBITDA is $12.66 M

What is Lipocine quarterly EBITDA year-on-year change?

Over the past year, LPCN quarterly EBITDA has changed by -$1.62 M (-160.71%)

What is Lipocine TTM EBITDA?

The current TTM EBITDA of LPCN is -$3.68 M

What is the all time high TTM EBITDA for Lipocine?

Lipocine all-time high TTM EBITDA is $4.16 M

What is Lipocine TTM EBITDA year-on-year change?

Over the past year, LPCN TTM EBITDA has changed by +$12.64 M (+77.45%)